Доступ предоставлен для: Guest
Critical Reviews™ in Immunology

Выходит 6 номеров в год

ISSN Печать: 1040-8401

ISSN Онлайн: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Negative Regulation of T-Cell Function by PD-1

Том 24, Выпуск 4, 2004, 10 pages
DOI: 10.1615/CritRevImmunol.v24.i4.10
Get accessGet access

Краткое описание

PD-1 is a receptor inducibly expressed on CD4+ and CD8+ T cells Mowing activation. PD-1-deficient mice develop signs of autoimmunity, suggesting a negative regulatory role for PD-1 in dampening lymphocyte responses. The expression of one ligand for PD-1, designated PD-L1 or B7-H1, on tumor cells of a variety of histologies has suggested a potential mechanism for tumor escape from immune destruction. This review summarizes data regarding PD-1 and related negative regulatory receptors, focusing on implications for potentiating antitumor immunity in vivo.

ЦИТИРОВАНО В
  1. Buckland M., Jago C. B., Fazekasova H., Scott K., Tan P. H., George A. J. T., Lechler R., Lombardi G., Aspirin-Treated Human DCs Up-Regulate ILT-3 and Induce Hyporesponsiveness and Regulatory Activity in Responder T Cells, American Journal of Transplantation, 6, 9, 2006. Crossref

  2. Gajewski Thomas F., Meng Yuru, Harlin Helena, Immune Suppression in the Tumor Microenvironment, Journal of Immunotherapy, 29, 3, 2006. Crossref

  3. McCoy M. J., Nowak A. K., Lake R. A., Chemoimmunotherapy: an emerging strategy for the treatment of malignant mesothelioma, Tissue Antigens, 74, 1, 2009. Crossref

  4. Kitazawa Yusuke, Fujino Masayuki, Wang Quanxing, Kimura Hiromitsu, Azuma Miyuki, Kubo Masato, Abe Ryo, Li Xiao-Kang, Involvement of the Programmed Death-1/Programmed Death-1 Ligand Pathway in CD4+CD25+ Regulatory T-Cell Activity to Suppress Alloimmune Responses, Transplantation, 83, 6, 2007. Crossref

  5. Croci Diego O., Zacarías Fluck Mariano F., Rico María J., Matar Pablo, Rabinovich Gabriel A., Scharovsky O. Graciela, Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment, Cancer Immunology, Immunotherapy, 56, 11, 2007. Crossref

  6. Chen Daniel S, Soen Yoav, Stuge Tor B, Lee Peter P, Weber Jeffrey S, Brown Patrick O, Davis Mark M, Rees Jonathan, Marked Differences in Human Melanoma Antigen-Specific T Cell Responsiveness after Vaccination Using a Functional Microarray, PLoS Medicine, 2, 10, 2005. Crossref

  7. Gajewski Thomas F., Meng Yuru, Blank Christian, Brown Ian, Kacha Aalok, Kline Justin, Harlin Helena, Immune resistance orchestrated by the tumor microenvironment, Immunological Reviews, 213, 1, 2006. Crossref

  8. SØRENSEN MARIA RATHMANN, THOMSEN ALLAN RANDRUP, Virus-based immunotherapy of cancer: what do we know and where are we going?, APMIS, 115, 11, 2007. Crossref

  9. Vieweg Johannes, Future directions for vaccine-based therapies, Urologic Oncology: Seminars and Original Investigations, 24, 5, 2006. Crossref

  10. Zhao Yong, Huang Zhihua, Qi Meirigeng, Lazzarini Ping, Mazzone Theodore, Immune regulation of T lymphocyte by a newly characterized human umbilical cord blood stem cell, Immunology Letters, 108, 1, 2007. Crossref

  11. Sun Yuping, Wang Yunshan, Zhao Jianqiang, Gu Ming, Giscombe Ricardo, Lefvert Ann Kari, Wang Xiongbiao, B7-H3 and B7-H4 expression in non-small-cell lung cancer, Lung Cancer, 53, 2, 2006. Crossref

  12. de Souza Malaspina Tatiana Salles, Gasparoto Thaís Helena, Costa Maria Renata Sales Nogueira, de Melo Edgard Franco, Ikoma Maura Rosane Valério, Damante José Humberto, Cavassani Karen Angélica, Garlet Gustavo Pompermaier, da Silva João Santana, Campanelli Ana Paula, Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma, Cancer Immunology, Immunotherapy, 60, 7, 2011. Crossref

  13. Velicu Simona, Han Yu, Ulasov Ilya, Brown Ian E., Andaloussi Abdel El, Gajewski Thomas F., Lesniak Maciej S., Cross-priming of T cells to intracranial tumor antigens elicits an immune response that fails in the effector phase but can be augmented with local immunotherapy, Journal of Neuroimmunology, 174, 1-2, 2006. Crossref

  14. Xerri Luc, Chetaille Bruno, Seriari Nacer, Attias Coralie, Guillaume Yves, Arnoulet Christine, Olive Daniel, Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia, Human Pathology, 39, 7, 2008. Crossref

  15. Hong Xuejun, Liu Yang, Hu Guili, Zhao Dekuang, Shen Jiangen, Shen Fenping, Cao Xuetao, Wang Qingqing, EBAG9 inducing hyporesponsiveness of T cells promotes tumor growth and metastasis in 4T1 murine mammary carcinoma, Cancer Science, 100, 5, 2009. Crossref

  16. Günaydın Rıza Önder, Kesikli Sacit Altuğ, Kansu Emin, Hoşal Ali Şefik, Identification of the peripheral blood levels of interleukin-12, interleukin-10, and transforming growth factor-β in patients with laryngeal squamous cell carcinoma, Head & Neck, 34, 3, 2012. Crossref

  17. Berrios Ricardo L., Arbiser Jack L., The Biology of Skin Cancer Invasion and Metastasis, in Cancer of the Skin, 2011. Crossref

  18. Rang HP, Dale MM, Ritter JM, Flower RJ, Cell proliferation and apoptosis, in Rang &amp Dale's Pharmacology, 2007. Crossref

  19. Rang H P, Dale M M, Ritter J M, Flower R J, Henderson G, Cell proliferation, apoptosis, repair and regeneration, in Rang &amp Dale's Pharmacology, 2012. Crossref

  20. Charles Ronald, Chou Hong-Shiue, Wang Lianfu, Fung John J., Lu Lina, Qian Shiguang, Human Hepatic Stellate Cells Inhibit T-Cell Response Through B7-H1 Pathway, Transplantation, 96, 1, 2013. Crossref

  21. Sharabi Andrew, Herman Joseph, Weiss Vivian, Laheru Daniel, Tuli Richard, Role of radiotherapy in combination with chemotherapy, targeted therapy, and immunotherapy in the management of pancreatic cancer, Journal of Radiation Oncology, 2, 4, 2013. Crossref

  22. Shin Seung-Pil, Seo Hye-Hyun, Shin Jae-Hun, Park Hyung-Bae, Lim Dong-Pyo, Eom Hyeon-Seok, Bae Yong-Soo, Kim In-Hoo, Choi Kyungho, Lee Sang-Jin, Adenovirus Expressing Both Thymidine Kinase and Soluble PD1 Enhances Antitumor Immunity by Strengthening CD8 T-cell Response, Molecular Therapy, 21, 3, 2013. Crossref

  23. Ghiringhelli François, Apetoh Lionel, The interplay between the immune system and chemotherapy: emerging methods for optimizing therapy, Expert Review of Clinical Immunology, 10, 1, 2014. Crossref

  24. Nelson Delia, Fisher Scott, Robinson Bruce, The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment, Journal of Immunology Research, 2014, 2014. Crossref

  25. Goldszmid Romina S., Dzutsev Amiran, Trinchieri Giorgio, Host Immune Response to Infection and Cancer: Unexpected Commonalities, Cell Host & Microbe, 15, 3, 2014. Crossref

  26. Apetoh L., Ladoire S., Coukos G., Ghiringhelli F., Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?, Annals of Oncology, 26, 9, 2015. Crossref

  27. Cortazar Frank B., Marrone Kristen A., Troxell Megan L., Ralto Kenneth M., Hoenig Melanie P., Brahmer Julie R., Le Dung T., Lipson Evan J., Glezerman Ilya G., Wolchok Jedd, Cornell Lynn D., Feldman Paul, Stokes Michael B., Zapata Sarah A., Hodi F. Stephen, Ott Patrick A., Yamashita Michifumi, Leaf David E., Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors, Kidney International, 90, 3, 2016. Crossref

  28. Zhang Lanfang, Xia Chang-Qing, PD-1/PD-L1 Interaction Maintains Allogeneic Immune Tolerance Induced by Administration of Ultraviolet B-Irradiated Immature Dendritic Cells, Journal of Immunology Research, 2016, 2016. Crossref

  29. Arefanian Hossein, Tredget Eric B., Mok Dereck C. M., Ramji Qahir, Rafati Shahin, Rodriguez-Barbosa Jose, Korbutt Gregory S., Rajotte Ray V., Gill Ron G., Rayat Gina R., Porcine Islet-Specific Tolerance Induced by the Combination of Anti-LFA-1 and Anti-CD154 mAbs is Dependent on PD-1, Cell Transplantation, 25, 2, 2016. Crossref

  30. Mao Lie, Hou Hongyan, Wu Shiji, Zhou Yu, Wang Juan, Yu Jing, Wu Xiaohui, Lu Yanfang, Mao Liyan, Bosco Munyemana Jean, Wang Feng, Sun Ziyong, TIGIT signalling pathway negatively regulates CD4+ T-cell responses in systemic lupus erythematosus, Immunology, 151, 3, 2017. Crossref

  31. Silva-Filho João L., Caruso-Neves Celso, Pinheiro Ana A. S., Targeting Angiotensin II Type-1 Receptor (AT1R) Inhibits the Harmful Phenotype of Plasmodium-Specific CD8+ T Cells during Blood-Stage Malaria, Frontiers in Cellular and Infection Microbiology, 7, 2017. Crossref

  32. Lau Audrey H., Abe Masanori, Thomson Angus W., Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo, Journal of Leukocyte Biology, 79, 5, 2006. Crossref

  33. Touzani Fahd, Pozdzik Agnieszka, New insights into immune cells cross-talk during IgG4-related disease, Clinical Immunology, 198, 2019. Crossref

  34. Wang F. F., Wang Y., Wang L., Wang T. S., Bai Y. P., TIGIT expression levels on CD4+ T cells are correlated with disease severity in patients with psoriasis, Clinical and Experimental Dermatology, 43, 6, 2018. Crossref

  35. Ritter Manuel, Ndongmo Winston Patrick Chounna, Njouendou Abdel Jelil, Nghochuzie Nora Nganyewo, Nchang Lucy Cho, Tayong Dizzle Bita, Arndts Kathrin, Nausch Norman, Jacobsen Marc, Wanji Samuel, Layland Laura E., Hoerauf Achim, Makepeace Benjamin L, Mansonella perstans microfilaremic individuals are characterized by enhanced type 2 helper T and regulatory T and B cell subsets and dampened systemic innate and adaptive immune responses, PLOS Neglected Tropical Diseases, 12, 1, 2018. Crossref

  36. Ishibashi Naoya, Watanabe Tatsuaki, Kanehira Masahiko, Watanabe Yui, Hoshikawa Yasushi, Notsuda Hirotsugu, Noda Masafumi, Sakurada Akira, Ohkouchi Shinya, Kondo Takashi, Okada Yoshinori, Bone marrow mesenchymal stromal cells protect allograft lung transplants from acute rejection via the PD-L1/IL-17A axis, Surgery Today, 48, 7, 2018. Crossref

  37. Bhatt Kamlesh, Uzelac Aleksandra, Mathur Sanjeev, McBride Amanda, Potian Julius, Salgame Padmini, B7 Costimulation Is Critical for Host Control of ChronicMycobacterium tuberculosisInfection, The Journal of Immunology, 182, 6, 2009. Crossref

  38. Pulko Vesna, Harris Kimberley J., Liu Xin, Gibbons Rachel M., Harrington Susan M., Krco Christopher J., Kwon Eugene D., Dong Haidong, B7-H1 Expressed by Activated CD8 T Cells Is Essential for Their Survival, The Journal of Immunology, 187, 11, 2011. Crossref

  39. Izawa Atsushi, Yamaura Kazuhiro, Albin Monica J., Jurewicz Mollie, Tanaka Katsunori, Clarkson Michael R., Ueno Takuya, Habicht Antje, Freeman Gordon J., Yagita Hideo, Abdi Reza, Pearson Todd, Greiner Dale L., Sayegh Mohamed H., Najafian Nader, A Novel Alloantigen-Specific CD8+PD1+Regulatory T Cell Induced by ICOS-B7h Blockade In Vivo, The Journal of Immunology, 179, 2, 2007. Crossref

  40. Shingarev Roman, Glezerman Ilya G., Kidney Complications of Immune Checkpoint Inhibitors: A Review, American Journal of Kidney Diseases, 74, 4, 2019. Crossref

  41. Gerner Michael Y., Heltemes-Harris Lynn M., Fife Brian T., Mescher Matthew F., Cutting Edge: IL-12 and Type I IFN Differentially Program CD8 T Cells for Programmed Death 1 Re-expression Levels and Tumor Control, The Journal of Immunology, 191, 3, 2013. Crossref

  42. Allie S. Rameeza, Zhang Weijun, Fuse Shinchiro, Usherwood Edward J., Programmed Death 1 Regulates Development of Central Memory CD8 T Cells after Acute Viral Infection, The Journal of Immunology, 186, 11, 2011. Crossref

  43. Sethi Tarsheen K., Kovach Alexandra E., Grover Natalie S., Huang Li-Ching, Lee Laura A., Rubinstein Samuel M., Wang Yang, Morgan David S., Greer John P., Park Steven I., Ann Thompson-Arildsen Mary, Yenamandra Ashwini, Vnencak-Jones Cindy L., Reddy Nishitha M., Clinicopathologic correlates of MYD88 L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphoma, Leukemia & Lymphoma, 60, 12, 2019. Crossref

  44. Georgianos Panagiotis I., Vaios Vasilios, Leontaridou Eleni, Karayannopoulou Georgia, Koletsa Triantafyllia, Sioulis Athanasios, Balaskas Elias V., Zebekakis Pantelis E., Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab, Case Reports in Nephrology, 2019, 2019. Crossref

  45. Serafini Paolo, Weed Donald T., The Immune System in Head and Neck Squamous Cell Carcinoma: Interactions and Therapeutic Opportunities, in Advances in Tumor Immunology and Immunotherapy, 2014. Crossref

  46. Bradley Jillian H., Barwick Shannon, Horn Gillian Q., Ullrich Elizabeth, Best Brianna, Arnold Jennifer P., Gregg Randal K., Simulated microgravity-mediated reversion of murine lymphoma immune evasion, Scientific Reports, 9, 1, 2019. Crossref

  47. Davar Diwakar, Fenton Moon, Appleman Leonard J., Immunotherapy for Renal Cell Carcinoma, in Renal Cell Carcinoma, 2013. Crossref

  48. Haque Azizul, Nagarkatti Mitzi, Nagarkatti Prakash, Banik Naren L., Ray Swapan K., Immunotherapy for Glioblastoma, in Glioblastoma, 2010. Crossref

  49. Babu Subash, Blauvelt Carla P., Kumaraswami V., Nutman Thomas B., Regulatory Networks Induced by Live Parasites Impair Both Th1 and Th2 Pathways in Patent Lymphatic Filariasis: Implications for Parasite Persistence, The Journal of Immunology, 176, 5, 2006. Crossref

  50. Lin Ziying, Xu Yutong, Zhang Yaxiong, He Qihua, Zhang Jianrong, He Jianxing, Liang Wenhua, The prevalence and clinicopathological features of programmed death-ligand 1 (PD-L1) expression: a pooled analysis of literatures, Oncotarget, 7, 12, 2016. Crossref

  51. Xiang Xiao, Yu Peng-Cheng, Long Di, Liao Xiao-Li, Zhang Sen, You Xue-Mei, Zhong Jian-Hong, Li Le-Qun, Prognostic value of PD -L1 expression in patients with primary solid tumors, Oncotarget, 9, 4, 2018. Crossref

  52. Jayathilake Abilasha G., Veale Margaret F., Luwor Rodney Brain, Nurgali Kulmira, Su Xiao Q., Krill oil extract inhibits the migration of human colorectal cancer cells and down-regulates EGFR signalling and PD-L1 expression, BMC Complementary Medicine and Therapies, 20, 1, 2020. Crossref

  53. Peng Xiaolun, Wang Yijia, Wen Wei, Chen Miao-Miao, Zhang Xiuhua, Wang Shengfu, Simple MoS2–Nanofiber Paper-Based Fluorescence Immunosensor for Point-of-Care Detection of Programmed Cell Death Protein 1, Analytical Chemistry, 93, 25, 2021. Crossref

  54. Liu Zhen, Sun Li, Cai Lei, Guo Man, Xu Guanghui, Liu Shushang, Zheng Gaozan, Wang Qiao, Lian Xiao, Feng Fan, Zhang Hongwei, Clinicopathological and prognostic values of PD-L1 expression in oesophageal squamous cell carcinoma: a meta-analysis of 31 studies with 5368 patients, Postgraduate Medical Journal, 2021. Crossref

  55. Venkatachari Narasimhan J., Buchanan William G., Ayyavoo Velpandi, Human immunodeficiency virus (HIV-1) infection selectively downregulates PD-1 expression in infected cells and protects the cells from early apoptosis in vitro and in vivo, Virology, 376, 1, 2008. Crossref

  56. Thompson R Houston, Kwon Eugene D, Allison James P, Inhibitors of B7–CD28 costimulation in urologic malignancies, Immunotherapy, 1, 1, 2009. Crossref

  57. Zang Peter D., Lee Ramon O., Smith Joshua A., Acute renal failure in patient with renal cell carcinoma after combination immune checkpoint inhibitor therapy, Current Problems in Cancer: Case Reports, 4, 2021. Crossref

  58. Abramiuk Monika, Grywalska Ewelina, Małkowska Paulina, Sierawska Olga, Hrynkiewicz Rafał, Niedźwiedzka-Rystwej Paulina, The Role of the Immune System in the Development of Endometriosis, Cells, 11, 13, 2022. Crossref

  59. Atkins Michael B., Elder David E., Essner Richard, Flaherty Keith T., Gajewski Thomas F., Haluska Frank G., Hwu Patrick, Keilholz Ulrich, Kirkwood John M., Mier James W., Ross Merrick I., Slingluff Craig L., Sondak Vernon K., Sosman Jeffrey A., Weinstock Martin A., King Laura, Innovations and Challenges in Melanoma: Summary Statement from the First Cambridge Conference, Clinical Cancer Research, 12, 7, 2006. Crossref

  60. DeLucia Diana C., Lee John K., Development of Cancer Immunotherapies, in Cancer Immunotherapies, 183, 2022. Crossref

  61. Thompson R. Houston, Dong Haidong, Lohse Christine M., Leibovich Bradley C., Blute Michael L., Cheville John C., Kwon Eugene D., PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma, Clinical Cancer Research, 13, 6, 2007. Crossref

  62. Boorjian Stephen A., Sheinin Yuri, Crispen Paul L., Farmer Sara A., Lohse Christine M., Kuntz Susan M., Leibovich Bradley C., Kwon Eugene D., Frank Igor, T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathologic Correlations and Association with Survival, Clinical Cancer Research, 14, 15, 2008. Crossref

  63. Gajewski Thomas F., Identifying and Overcoming Immune Resistance Mechanisms in the Melanoma Tumor Microenvironment, Clinical Cancer Research, 12, 7, 2006. Crossref

  64. Weishaupt Carsten, Munoz Karla N., Buzney Elizabeth, Kupper Thomas S., Fuhlbrigge Robert C., T-Cell Distribution and Adhesion Receptor Expression in Metastatic Melanoma, Clinical Cancer Research, 13, 9, 2007. Crossref

  65. Freiser Monika E., Serafini Paolo, Weed Donald T., The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities, Immunologic Research, 57, 1-3, 2013. Crossref

  66. Li Shu, Xu He, Kirk Allan D., Modulation of Xenogeneic T-cell Proliferation by B7 and mTOR Blockade of T Cells and Porcine Endothelial Cells, Transplantation, 106, 5, 2022. Crossref

  67. Tahir Imtiaz Mahmood, Rauf Abdur, Mehboob Huma, Sadaf Samia, Alam Muhammad Shaiful, Kalsoom Fadia, Bouyahya Abdelhakim, El Allam Aicha, El Omari Nasreddine, Bakrim Saad, Akram Muhammad, Raza Syed Kashif, Emran Talha Bin, Mabkhot Yahia N., Zengin Gokhan, Derkho Marina, Natalya Suray, Shariati Mohammad Ali, Prognostic significance of programmed death-1 and programmed death ligand-1 proteins in breast cancer, Human Antibodies, 30, 3, 2022. Crossref

Статьи, принятые к публикации

Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain